Market Overview:
The global drugs for anti-infective market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing incidence of infectious diseases, rising demand for novel antibiotics, and growing awareness about hygiene and preventive measures. The global drugs for anti-infective market is segmented on the basis of type into OTC drugs and Rx drugs. The OTC drug segment is projected to grow at a higher CAGR than the Rx drug segment during the forecast period. This can be attributed to factors such as ease of availability and lower cost of OTC drugs as compared with Rx drugs. On the basis of application, the global Drugs for Anti-Infectives Market is divided into three segments: hospital pharmacies, retail pharmacies (drug stores), and other applications (including clinics, long term care facilities, research institutes/laboratories). The hospital pharmacy segment accounted for majority share in 2017 and is projected to maintain its dominance during the forecast period owing to increasing number of surgeries performed in hospitals coupled with rising prevalence rates of hospital acquired infections (HAIs). However, over time there has been an increase in demand from end users such as patients & consumers towards self-medication or use through local chemists or druggists which might hamper growth prospects offered by this particular application area over next few years .
Product Definition:
A drug is any substance that, when taken into the body, alters the way the body works. Drugs can be used for medical purposes to treat diseases or conditions, or they can be used illegally to get high.
An anti-infective drug is a type of medication that is used to treat infections caused by bacteria, viruses, or parasites. These drugs work by killing or stopping the growth of these organisms. Anti-infective drugs are important for treating infections and preventing them from spreading.
OTC:
OTC stands for Over-the-Counter. OTC drugs are medicines that can be used without a prescription. They can be purchased from pharmacies and other retail outlets without any medical prescription. Most of the time, these products do not have to go through an FDA approval process before being sold in stores as OTC medications.
Rx Drugs:
Rx drugs are the ones that are purchased from pharmacies and drugstores without a doctor's prescription. They are used to treat temporary ailments or chronic conditions like allergies, colds, bronchitis, etc. The global anti-infective market is expected to grow at a significant rate during the forecast period owing to increasing incidences of hospital acquired infections coupled with rising awareness levels about self-care and hand hygiene among patients.
Application Insights:
The other application segment held the largest share of the global drugs for anti-infective market in 2017. This is due to growing incidences of hospital acquired infections and increasing number of deaths caused by drug-resistant bacteria. For instance, according to a study published in The Journal Of Infectious Diseases, around 1 in 5 patients suffering from a urinary tract infection dies as compared to only 1 in 10 people who have a bladder infection outside hospitals. Similarly, about 7 out of 10 deaths caused by Clostridium difficile are observed within 2 weeks after discharge from hospitals whereas before this date death caused by C difficile was rarer than death due to kidney or liver failure.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position throughout the forecast period owing to increasing prevalence of infectious diseases, rising geriatric population, and availability of a strong distribution network. Moreover, high R&D investment by companies for development of novel drugs is also one among the key factors contributing toward growth in this region.
Asia Pacific is estimated to be fastest-growing regional market during the forecast period due to various factors such as improving economic conditions and growing healthcare spending especially by governments in developing countries like India and China. In addition, increasing awareness about infectious diseases among people will drive demand for anti-infective drugs over next eight years.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the key growth drivers for the drugs for anti-infective market. This is because infections are becoming more resistant to antibiotics, thereby necessitating the use of newer and more potent drugs.
- Growing demand for novel anti-infective agents: The growing demand for novel anti-infective agents is another key growth driver for this market. This is because there are a limited number of approved anti-infective agents available in the market, and there exists a high unmet need for new and better drugs to treat various infections.
- Rising prevalence of multi-drug resistant pathogens: The rising prevalence of multi drug resistant pathogens is another major factor that is driving the growth of this market. Multi drug resistance poses a serious threat to public health as it can lead to untreatable infections, which can be fatal in some cases..
Scope Of The Report
Report Attributes
Report Details
Report Title
Drugs for Anti-Infective Market Research Report
By Type
OTC, Rx Drugs
By Application
Hospital, Drugs Store, Other
By Companies
GlaxoSmithKline, Merck, Pfizer, Novartis AG, Gilead Sciences, Abbott, Wyeth, Sanofi-Aventis, Bristol-Myers Squibb, Johnson, GlaxoSmithKline, Nanosphere, NanoViricides, Novabay Pharmaceuticals, Obetech, Optimer Pharmaceuticals, Basilea Pharmaceutica AG, Daiichi Sankyo, MerLion Pharma, Theravance
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
185
Number of Tables & Figures
130
Customization Available
Yes, the report can be customized as per your need.
Global Drugs for Anti-Infective Market Report Segments:
The global Drugs for Anti-Infective market is segmented on the basis of:
Types
OTC, Rx Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drugs Store, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- Merck
- Pfizer
- Novartis AG
- Gilead Sciences
- Abbott
- Wyeth
- Sanofi-Aventis
- Bristol-Myers Squibb
- Johnson
- GlaxoSmithKline
- Nanosphere
- NanoViricides
- Novabay Pharmaceuticals
- Obetech
- Optimer Pharmaceuticals
- Basilea Pharmaceutica AG
- Daiichi Sankyo
- MerLion Pharma
- Theravance
Highlights of The Drugs for Anti-Infective Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- OTC
- Rx Drugs
- By Application:
- Hospital
- Drugs Store
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drugs for Anti-Infective Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drugs for anti-infective are used to treat infections caused by bacteria, viruses, or fungi. These drugs can help to prevent the spread of infection and may also help to relieve symptoms.
Some of the major companies in the drugs for anti-infective market are GlaxoSmithKline, Merck, Pfizer, Novartis AG, Gilead Sciences, Abbott, Wyeth, Sanofi-Aventis, Bristol-Myers Squibb, Johnson, GlaxoSmithKline, Nanosphere, NanoViricides, Novabay Pharmaceuticals, Obetech, Optimer Pharmaceuticals, Basilea Pharmaceutica AG, Daiichi Sankyo, MerLion Pharma, Theravance.
The drugs for anti-infective market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drugs for Anti-Infective Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Drugs for Anti-Infective Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Drugs for Anti-Infective Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Drugs for Anti-Infective Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Drugs for Anti-Infective Market Size & Forecast, 2020-2028
4.5.1 Drugs for Anti-Infective Market Size and Y-o-Y Growth
4.5.2 Drugs for Anti-Infective Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 OTC
5.2.2 Rx Drugs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drugs Store
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Drugs for Anti-Infective Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Drugs for Anti-Infective Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 OTC
9.6.2 Rx Drugs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drugs Store
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 OTC
10.6.2 Rx Drugs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drugs Store
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 OTC
11.6.2 Rx Drugs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drugs Store
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 OTC
12.6.2 Rx Drugs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drugs Store
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 OTC
13.6.2 Rx Drugs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drugs Store
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Drugs for Anti-Infective Market: Competitive Dashboard
14.2 Global Drugs for Anti-Infective Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline
14.3.2 Merck
14.3.3 Pfizer
14.3.4 Novartis AG
14.3.5 Gilead Sciences
14.3.6 Abbott
14.3.7 Wyeth
14.3.8 Sanofi-Aventis
14.3.9 Bristol-Myers Squibb
14.3.10 Johnson
14.3.11 GlaxoSmithKline
14.3.12 Nanosphere
14.3.13 NanoViricides
14.3.14 Novabay Pharmaceuticals
14.3.15 Obetech
14.3.16 Optimer Pharmaceuticals
14.3.17 Basilea Pharmaceutica AG
14.3.18 Daiichi Sankyo
14.3.19 MerLion Pharma
14.3.20 Theravance
